Iphosphamide-induced nephrotoxicity in children

Richard Shore, Mark Greenberg, Dennis Geary, Gideon Koren

Research output: Contribution to journalArticlepeer-review

40 Scopus citations


The nephrotoxic potential of iphosphamide was evaluated in a retrospective analysis of all children receiving the drug at The Hospital for Sick Children in Toronto. The 25 children exhibiting nephrotoxicity did not receive more cycles or higher doses per square metre than the 78 with normal renal function. Similarly, the two groups received comparable doses and number of cycles of sodium 2-mercaptoethanesulphonate, and had similar rates of exposure to nephrotoxic drugs (except for cis-platinum). Children exhibiting nephrotoxicity were significantly younger (78.1±64.1 months) than those having normal kidney function (103.8±66.6 months) (P<0.05). Children exhibiting nephrotoxicity were more likely to have received cis-platinum prior to the iphosphamide (10/25, 40%) than those with normal renal function (14/73, 18%) (P<0.05). Nephrotoxicity was associated with a significant effect on growth. Careful follow-up of renal function should take place in children receiving iphosphamide, with special attention paid to children younger than 5 years of age and those who have received cis-platinum.

Original languageEnglish
Pages (from-to)162-165
Number of pages4
JournalPediatric Nephrology
Issue number2
StatePublished - Mar 1992
Externally publishedYes


Dive into the research topics of 'Iphosphamide-induced nephrotoxicity in children'. Together they form a unique fingerprint.

Cite this